Status | Study |
Recruiting |
Study Name: Parathyroid Cancer Versus Atypical Parathyroid Neoplasm; Investigating Their Clinical Characteristics and Biological Behavior Condition: Parathyroid Carcinoma Parathyroid Neoplasm Date: 2017-02-02 Interventions: Other: Chart Review Data between the years of 1/1/2002 and 12/31/2013 analyzed. |
Recruiting |
Study Name: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Condition: Acinar Cell Carcinoma Adrenal Cortex Carcinoma Adrenal Gla Date: 2016-07-13 Interventions: Procedure: Biospecimen Collection |
Completed |
Study Name: An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism Condition: Parathyroid Carcinoma Hypercalcemia Date: 2011-10-25 Interventions: Drug: Cinacalcet HCl Oral administration |
Completed |
Study Name: External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Condition: Cancer Date: 2008-03-14 Interventions: Drug: indinavir sulfate Drug: ritonavir |
Completed |
Study Name: Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma Condition: Melanoma Soft Tissue Sarcoma Parathy Date: 2007-12-18 Interventions: Drug: Dacarbazine and bortezomib Level 0: Dacarbazine 190 mg/m2 + Bortezomib 1.0 mg/m2; Level 1: Dacarba |
Completed |
Study Name: NGR-TNF in Treating Patients With Advanced Solid Tumors Condition: Colorectal Cancer Head and Neck Cancer Kidney Cancer Date: 2004-12-08 Interventions: Biological: CNGRC peptide-TNF alpha conjugate |
Completed |
Study Name: Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer Condition: Anaplastic Thyroid Cancer Insular Thyroid Cancer Metastati Date: 2003-09-10 Interventions: Drug: gefitinib Given orally Other Names: |
Completed |
Study Name: A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer Condition: Hyperparathyroidism Parathyroid Neoplasms Date: 2002-05-17 Interventions: Drug: AMG 073 |
Completed |
Study Name: MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma Condition: Cancer Date: 2001-07-11 Interventions: Drug: entinostat |
Completed |
Study Name: Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer Condition: Cancer Date: 2000-06-02 Interventions: Biological: trastuzumab Drug: tipifarnib |